BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12605981)

  • 1. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores.
    Hoeller U; Tribius S; Kuhlmey A; Grader K; Fehlauer F; Alberti W
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1013-8. PubMed ID: 12605981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the RTOG/EORTC and LENT-SOMA scoring systems for the evaluation of late skin toxicity after
    Mao MH; Zhang J; Zhang JG
    Brachytherapy; 2017; 16(4):877-883. PubMed ID: 28495444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system.
    Fehlauer F; Tribius S; Höller U; Rades D; Kuhlmey A; Bajrovic A; Alberti W
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):651-8. PubMed ID: 12573752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems.
    Anacak Y; Yalman D; Ozsaran Z; Haydaroğlu A
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1107-12. PubMed ID: 11483319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late radiation effects to the rectum and anus after treatment for prostate cancer; validity of the LENT/SOMA score.
    Lund JÅ; Kaasa S; Wibe A; Widmark A; Fransson P
    Acta Oncol; 2013 May; 52(4):727-35. PubMed ID: 23398595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems.
    Denis F; Garaud P; Bardet E; Alfonsi M; Sire C; Germain T; Bergerot P; Rhein B; Tortochaux J; Oudinot P; Calais G
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):93-8. PubMed ID: 12504040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [T.i.d. accelerated radiotherapy alone or alternating with chemotherapy in patients with a locally advanced ORL cancer: analysis of late toxicity].
    Laszlo A; Rosset A; Hermann F; Ozsahin M; Zouhair A; Mirimanoff RO
    Cancer Radiother; 2001 Apr; 5(2):130-7. PubMed ID: 11355577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue compliance meter is a more reproducible method of measuring radiation-induced fibrosis than late effects of normal tissue-subjective objective management analytical in patients treated with intracavitary brachytherapy accelerated partial breast irradiation: results of a prospective trial.
    Wernicke AG; Greenwood EA; Coplowitz S; Parashar B; Kulidzhanov F; Christos PJ; Fischer A; Nori D; Chao KS
    Breast J; 2013; 19(3):250-8. PubMed ID: 23614363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].
    Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Miny-Buffet J; Favre A; Azria D; Body G; Le Floch O; Calais G
    Cancer Radiother; 2006 Jun; 10(4):158-67. PubMed ID: 16632399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conservative treatment of extremity soft tissue sarcomas. Functional evaluation using LENT-SOMA scales and Enneking scoring].
    Tawfiq N; Lagarde P; Stöckle E; Thomas L; Bui BN; Kantor G
    Cancer Radiother; 2000; 4(6):421-7. PubMed ID: 11191848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
    Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Breteau N; Body G; Azria D; Le Floch O; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):324-32. PubMed ID: 16542788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy.
    Gothard L; Cornes P; Brooker S; Earl J; Glees J; Hall E; Peckitt C; Tait D; Yarnold J
    Radiother Oncol; 2005 Jun; 75(3):334-41. PubMed ID: 16086914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary.
    Davidson SE; Burns MP; Routledge JA; Swindell R; Bentzen SM; West CM
    Radiother Oncol; 2003 Nov; 69(2):195-200. PubMed ID: 14643958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CD4
    Veldwijk MR; Seibold P; Botma A; Helmbold I; Sperk E; Giordano FA; Gürth N; Kirchner A; Behrens S; Wenz F; Chang-Claude J; Herskind C
    Clin Cancer Res; 2019 Jan; 25(2):562-572. PubMed ID: 30327309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is grading of breast fibrosis with mammography feasible?
    Hoeller U; Grzyska B; Lorenzen J; Kuhlmey A; Alberti W; Adam G
    Strahlenther Onkol; 2005 May; 181(5):307-12. PubMed ID: 15900426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.
    Boersma LJ; van den Brink M; Bruce AM; Shouman T; Gras L; te Velde A; Lebesque JV
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):83-92. PubMed ID: 9588921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.
    Michalski JM; Winter K; Purdy JA; Wilder RB; Perez CA; Roach M; Parliament MB; Pollack A; Markoe AM; Harms W; Sandler HM; Cox JD
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):192-8. PubMed ID: 12694838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam
    Key S; Miglierini P; Dupré PF; Guilbert S; Lucia AS; Abgral R; Conan-Charlet V; Uguen A; Pradier O; Schick U
    Ann Surg Oncol; 2017 Sep; 24(9):2547-2555. PubMed ID: 28608120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measures of late effects in conservative treatment of breast cancer with standard or hypofractionated radiotherapy.
    Marcenaro M; Sacco S; Pentimalli S; Berretta L; Andretta V; Grasso R; Parodi RC; Guarrera M; Scarpati D
    Tumori; 2004; 90(6):586-91. PubMed ID: 15762361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cosmesis from the patient's and the doctor's view.
    Hoeller U; Kuhlmey A; Bajrovic A; Grader K; Berger J; Tribius S; Fehlauer F; Alberti W
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):345-54. PubMed ID: 12957244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.